Is STEX or TELA more profitable?

Biosig Technologies has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. Biosig Technologies' return on equity of -717.92% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets Biosig Technologies N/A -717.92% -336.75% TELA Bio -49.30% -1,320.81% -55.83%

Does the media prefer STEX or TELA?

In the previous week, Biosig Technologies and Biosig Technologies both had 2 articles in the media. Biosig Technologies' average media sentiment score of 1.89 beat TELA Bio's score of 1.54 indicating that Biosig Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biosig Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive TELA Bio 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has preferable valuation and earnings, TELA or CVRX?

TELA Bio has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TELA Bio $80.28M 0.44 -$38.83M -$0.79 N/A CVRx $56.65M 2.40 -$53.31M -$2.02 N/A

Is TELA or CVRX more profitable?

TELA Bio has a net margin of -49.30% compared to CVRx's net margin of -89.14%. CVRx's return on equity of -120.76% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -49.30% -1,320.81% -55.83% CVRx -89.14% -120.76% -48.38%

Does the media favor TELA or CVRX?

In the previous week, TELA Bio and TELA Bio both had 2 articles in the media. TELA Bio's average media sentiment score of 1.54 beat CVRx's score of 0.93 indicating that TELA Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, TELA or GUTS?

TELA Bio has higher revenue and earnings than Fractyl Health. TELA Bio is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TELA Bio $80.28M 0.44 -$38.83M -$0.79 N/A Fractyl Health $90K 1,477.21 -$140.95M -$1.29 N/A

Is TELA or GUTS more profitable?

Fractyl Health has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. TELA Bio's return on equity of -1,320.81% beat Fractyl Health's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -49.30% -1,320.81% -55.83% Fractyl Health N/A -4,053.15% -96.41%

Does the media favor TELA or GUTS?

In the previous week, Fractyl Health had 5 more articles in the media than TELA Bio. MarketBeat recorded 7 mentions for Fractyl Health and 2 mentions for TELA Bio. TELA Bio's average media sentiment score of 1.54 beat Fractyl Health's score of 0.67 indicating that TELA Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Fractyl Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Is TELA or MBOT more profitable?

Microbot Medical has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. Microbot Medical's return on equity of -21.84% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -49.30% -1,320.81% -55.83% Microbot Medical N/A -21.84% -20.71%

Does the media favor TELA or MBOT?

In the previous week, Microbot Medical had 9 more articles in the media than TELA Bio. MarketBeat recorded 11 mentions for Microbot Medical and 2 mentions for TELA Bio. TELA Bio's average media sentiment score of 1.54 beat Microbot Medical's score of 1.38 indicating that TELA Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, TELA or RCEL?

TELA Bio has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TELA Bio $80.28M 0.44 -$38.83M -$0.79 N/A Avita Medical $71.61M 2.08 -$48.59M -$1.57 N/A

Is TELA or RCEL more profitable?

TELA Bio has a net margin of -49.30% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -49.30% -1,320.81% -55.83% Avita Medical -62.67% N/A -78.92%

Does the media favor TELA or RCEL?

In the previous week, Avita Medical had 1 more articles in the media than TELA Bio. MarketBeat recorded 3 mentions for Avita Medical and 2 mentions for TELA Bio. TELA Bio's average media sentiment score of 1.54 beat Avita Medical's score of 1.00 indicating that TELA Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Avita Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

TELA Bio (TELA) Competitors

$0.79 +0.04 (+4.85%)

As of 12:35 PM Eastern

Compare

TELA vs. STEX, CVRX, GUTS, MBOT, and RCEL

Should you buy TELA Bio stock or one of its competitors? MarketBeat compares TELA Bio with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with TELA Bio include Biosig Technologies (STEX), CVRx (CVRX), Fractyl Health (GUTS), Microbot Medical (MBOT), and Avita Medical (RCEL). These companies are all part of the "medical equipment" industry.

How does TELA Bio compare to Biosig Technologies?

Biosig Technologies (NASDAQ:STEX) and TELA Bio (NASDAQ:TELA) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.

7.2% of Biosig Technologies shares are owned by institutional investors. Comparatively, 94.4% of TELA Bio shares are owned by institutional investors. 52.7% of Biosig Technologies shares are owned by insiders. Comparatively, 5.1% of TELA Bio shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

TELA Bio has higher revenue and earnings than Biosig Technologies. TELA Bio is trading at a lower price-to-earnings ratio than Biosig Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biosig Technologies	$40K	3,554.19	-$462.77M	-$9.71	N/A
TELA Bio	$80.28M	0.44	-$38.83M	-$0.79	N/A

In the previous week, Biosig Technologies and Biosig Technologies both had 2 articles in the media. Biosig Technologies' average media sentiment score of 1.89 beat TELA Bio's score of 1.54 indicating that Biosig Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biosig Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
TELA Bio	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Biosig Technologies has a beta of 1.94, suggesting that its share price is 94% more volatile than the broader market. Comparatively, TELA Bio has a beta of 1.34, suggesting that its share price is 34% more volatile than the broader market.

Biosig Technologies currently has a consensus price target of $8.00, indicating a potential upside of 923.02%. TELA Bio has a consensus price target of $2.20, indicating a potential upside of 179.54%. Given Biosig Technologies' higher probable upside, research analysts clearly believe Biosig Technologies is more favorable than TELA Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biosig Technologies	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Biosig Technologies has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. Biosig Technologies' return on equity of -717.92% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biosig Technologies	N/A	-717.92%	-336.75%
TELA Bio	-49.30%	-1,320.81%	-55.83%

Summary

Biosig Technologies beats TELA Bio on 8 of the 15 factors compared between the two stocks.

How does TELA Bio compare to CVRx?

TELA Bio (NASDAQ:TELA) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation.

In the previous week, TELA Bio and TELA Bio both had 2 articles in the media. TELA Bio's average media sentiment score of 1.54 beat CVRx's score of 0.93 indicating that TELA Bio is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TELA Bio	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TELA Bio has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.28M	0.44	-$38.83M	-$0.79	N/A
CVRx	$56.65M	2.40	-$53.31M	-$2.02	N/A

TELA Bio has a beta of 1.34, indicating that its stock price is 34% more volatile than the broader market. Comparatively, CVRx has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market.

TELA Bio has a net margin of -49.30% compared to CVRx's net margin of -89.14%. CVRx's return on equity of -120.76% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-49.30%	-1,320.81%	-55.83%
CVRx	-89.14%	-120.76%	-48.38%

TELA Bio presently has a consensus price target of $2.20, indicating a potential upside of 179.54%. CVRx has a consensus price target of $11.50, indicating a potential upside of 124.39%. Given TELA Bio's higher possible upside, equities analysts clearly believe TELA Bio is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

94.4% of TELA Bio shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 5.1% of TELA Bio shares are held by insiders. Comparatively, 13.9% of CVRx shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

TELA Bio beats CVRx on 10 of the 16 factors compared between the two stocks.

How does TELA Bio compare to Fractyl Health?

TELA Bio (NASDAQ:TELA) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, media sentiment, dividends, earnings and risk.

In the previous week, Fractyl Health had 5 more articles in the media than TELA Bio. MarketBeat recorded 7 mentions for Fractyl Health and 2 mentions for TELA Bio. TELA Bio's average media sentiment score of 1.54 beat Fractyl Health's score of 0.67 indicating that TELA Bio is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TELA Bio	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Fractyl Health	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

94.4% of TELA Bio shares are owned by institutional investors. 5.1% of TELA Bio shares are owned by insiders. Comparatively, 8.5% of Fractyl Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

TELA Bio presently has a consensus price target of $2.20, suggesting a potential upside of 179.54%. Fractyl Health has a consensus price target of $5.12, suggesting a potential upside of 510.98%. Given Fractyl Health's stronger consensus rating and higher possible upside, analysts clearly believe Fractyl Health is more favorable than TELA Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Fractyl Health has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. TELA Bio's return on equity of -1,320.81% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-49.30%	-1,320.81%	-55.83%
Fractyl Health	N/A	-4,053.15%	-96.41%

TELA Bio has a beta of 1.34, indicating that its share price is 34% more volatile than the broader market. Comparatively, Fractyl Health has a beta of 2.29, indicating that its share price is 129% more volatile than the broader market.

TELA Bio has higher revenue and earnings than Fractyl Health. TELA Bio is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.28M	0.44	-$38.83M	-$0.79	N/A
Fractyl Health	$90K	1,477.21	-$140.95M	-$1.29	N/A

Summary

Fractyl Health beats TELA Bio on 9 of the 16 factors compared between the two stocks.

How does TELA Bio compare to Microbot Medical?

TELA Bio (NASDAQ:TELA) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

94.4% of TELA Bio shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 5.1% of TELA Bio shares are owned by company insiders. Comparatively, 4.7% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

TELA Bio currently has a consensus target price of $2.20, suggesting a potential upside of 179.54%. Microbot Medical has a consensus target price of $6.63, suggesting a potential upside of 277.49%. Given Microbot Medical's stronger consensus rating and higher probable upside, analysts plainly believe Microbot Medical is more favorable than TELA Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

In the previous week, Microbot Medical had 9 more articles in the media than TELA Bio. MarketBeat recorded 11 mentions for Microbot Medical and 2 mentions for TELA Bio. TELA Bio's average media sentiment score of 1.54 beat Microbot Medical's score of 1.38 indicating that TELA Bio is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TELA Bio	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TELA Bio has a beta of 1.34, suggesting that its stock price is 34% more volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.04, suggesting that its stock price is 4% more volatile than the broader market.

Microbot Medical has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. Microbot Medical's return on equity of -21.84% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-49.30%	-1,320.81%	-55.83%
Microbot Medical	N/A	-21.84%	-20.71%

Microbot Medical has lower revenue, but higher earnings than TELA Bio. Microbot Medical is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.28M	0.44	-$38.83M	-$0.79	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

Summary

Microbot Medical beats TELA Bio on 9 of the 16 factors compared between the two stocks.

How does TELA Bio compare to Avita Medical?

TELA Bio (NASDAQ:TELA) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

94.4% of TELA Bio shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 5.1% of TELA Bio shares are owned by insiders. Comparatively, 2.2% of Avita Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Avita Medical had 1 more articles in the media than TELA Bio. MarketBeat recorded 3 mentions for Avita Medical and 2 mentions for TELA Bio. TELA Bio's average media sentiment score of 1.54 beat Avita Medical's score of 1.00 indicating that TELA Bio is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TELA Bio	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Avita Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TELA Bio has a net margin of -49.30% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-49.30%	-1,320.81%	-55.83%
Avita Medical	-62.67%	N/A	-78.92%

TELA Bio has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.28M	0.44	-$38.83M	-$0.79	N/A
Avita Medical	$71.61M	2.08	-$48.59M	-$1.57	N/A

TELA Bio presently has a consensus price target of $2.20, suggesting a potential upside of 179.54%. Avita Medical has a consensus price target of $7.25, suggesting a potential upside of 50.10%. Given TELA Bio's higher probable upside, research analysts plainly believe TELA Bio is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

TELA Bio has a beta of 1.34, suggesting that its stock price is 34% more volatile than the broader market. Comparatively, Avita Medical has a beta of 1.86, suggesting that its stock price is 86% more volatile than the broader market.

Summary

TELA Bio beats Avita Medical on 10 of the 16 factors compared between the two stocks.

Get TELA Bio News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TELA vs. The Competition

Export

Metric	TELA Bio	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$35.23M	$3.69B	$6.87B	$12.28B
Dividend Yield	N/A	2.20%	2.68%	8.87%
P/E Ratio	-1.00	21.35	27.22	23.92
Price / Sales	0.44	305.18	581.69	113.21
Price / Cash	N/A	146.26	49.25	59.89
Price / Book	4.92	8.41	10.72	6.21
Net Income	-$38.83M	$23.83M	$3.59B	$331.73M
7 Day Performance	-7.08%	-3.35%	-2.12%	-2.18%
1 Month Performance	-8.39%	3.50%	2.12%	-1.53%
1 Year Performance	-60.25%	44.65%	24.56%	16.99%

TELA Bio Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TELA TELA Bio	2.8082 of 5 stars	$0.79 +4.8%	$2.20 +179.5%	-62.3%	$35.23M	$80.28M	N/A	120	News Coverage Positive News Gap Up
STEX Biosig Technologies	3.4564 of 5 stars	$0.82 -2.1%	$8.00 +873.2%	N/A	$149.62M	$40K	N/A	50	News Coverage Positive News Buyback Announcement
CVRX CVRx	1.9496 of 5 stars	$5.12 -5.7%	$11.50 +124.7%	-36.2%	$137.08M	$56.65M	N/A	160
GUTS Fractyl Health	4.3468 of 5 stars	$0.80 +5.3%	$5.12 +538.4%	-47.9%	$127.40M	$90K	N/A	102
MBOT Microbot Medical	2.7723 of 5 stars	$1.87 -0.8%	$6.63 +255.2%	-29.8%	$125.21M	N/A	N/A	20	Positive News Analyst Forecast Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TELA) was last updated on 7/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TELA Bio (TELA) Competitors

TELA vs. STEX, CVRX, GUTS, MBOT, and RCEL

How does TELA Bio compare to Biosig Technologies?

Summary

How does TELA Bio compare to CVRx?

Summary

How does TELA Bio compare to Fractyl Health?

Summary

How does TELA Bio compare to Microbot Medical?

Summary

How does TELA Bio compare to Avita Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TELA vs. The Competition

TELA Bio Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

TELA Bio (TELA) Competitors

TELA vs. STEX, CVRX, GUTS, MBOT, and RCEL

How does TELA Bio compare to Biosig Technologies?

Do institutionals & insiders believe in STEX or TELA?

Which has stronger earnings and valuation, STEX or TELA?

Does the media prefer STEX or TELA?

Which has more risk & volatility, STEX or TELA?

Do analysts recommend STEX or TELA?

Is STEX or TELA more profitable?

Summary

How does TELA Bio compare to CVRx?

Does the media favor TELA or CVRX?

Which has preferable valuation and earnings, TELA or CVRX?

Which has more risk & volatility, TELA or CVRX?

Is TELA or CVRX more profitable?

Do analysts rate TELA or CVRX?

Do insiders and institutionals believe in TELA or CVRX?

Summary

How does TELA Bio compare to Fractyl Health?

Does the media favor TELA or GUTS?

Do institutionals and insiders hold more shares of TELA or GUTS?

Do analysts rate TELA or GUTS?

Is TELA or GUTS more profitable?

Which has more risk and volatility, TELA or GUTS?

Which has stronger earnings and valuation, TELA or GUTS?

Summary

How does TELA Bio compare to Microbot Medical?

Do insiders and institutionals have more ownership in TELA or MBOT?

Do analysts prefer TELA or MBOT?

Does the media favor TELA or MBOT?

Which has more risk and volatility, TELA or MBOT?

Is TELA or MBOT more profitable?

Which has better valuation & earnings, TELA or MBOT?

Summary

How does TELA Bio compare to Avita Medical?

Do insiders & institutionals have more ownership in TELA or RCEL?

Does the media favor TELA or RCEL?

Is TELA or RCEL more profitable?

Which has higher earnings and valuation, TELA or RCEL?

Do analysts prefer TELA or RCEL?

Which has more volatility and risk, TELA or RCEL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TELA vs. The Competition

TELA Bio Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools